HK1061811A1 - Stable salts of o-acetylsalicyclic with basic amino acids - Google Patents

Stable salts of o-acetylsalicyclic with basic amino acids

Info

Publication number
HK1061811A1
HK1061811A1 HK04104934A HK04104934A HK1061811A1 HK 1061811 A1 HK1061811 A1 HK 1061811A1 HK 04104934 A HK04104934 A HK 04104934A HK 04104934 A HK04104934 A HK 04104934A HK 1061811 A1 HK1061811 A1 HK 1061811A1
Authority
HK
Hong Kong
Prior art keywords
acetylsalicyclic
amino acids
basic amino
stable salts
salts
Prior art date
Application number
HK04104934A
Inventor
Gerhard Franckowiak
Hubert Appolt
Gregor Leifker
Hans-Peter Wirges
Wolfram Ledwoch
Original Assignee
Bayer Healthcare Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag
Publication of HK1061811A1 publication Critical patent/HK1061811A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/612—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid
    • A61K31/616—Salicylic acid; Derivatives thereof having the hydroxy group in position 2 esterified, e.g. salicylsulfuric acid by carboxylic acids, e.g. acetylsalicylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/26—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having more than one amino group bound to the carbon skeleton, e.g. lysine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
HK04104934A 2000-07-18 2004-07-07 Stable salts of o-acetylsalicyclic with basic amino acids HK1061811A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10034802A DE10034802A1 (en) 2000-07-18 2000-07-18 Stable salts of O-acetylsalicylic acid with basic amino acids
PCT/EP2001/007669 WO2002005782A2 (en) 2000-07-18 2001-07-05 Stable salts of o-acetylsalicyclic with basic amino acids

Publications (1)

Publication Number Publication Date
HK1061811A1 true HK1061811A1 (en) 2004-10-08

Family

ID=7649258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04104934A HK1061811A1 (en) 2000-07-18 2004-07-07 Stable salts of o-acetylsalicyclic with basic amino acids

Country Status (34)

Country Link
US (2) US6773724B2 (en)
EP (1) EP1365737B1 (en)
JP (2) JP2004507463A (en)
KR (1) KR100773658B1 (en)
CN (1) CN1205176C (en)
AR (1) AR030305A1 (en)
AT (1) ATE293589T1 (en)
AU (2) AU7847101A (en)
BR (1) BR0112538A (en)
CA (1) CA2416288C (en)
CR (1) CR6888A (en)
CZ (1) CZ300337B6 (en)
DE (2) DE10034802A1 (en)
DK (1) DK1365737T3 (en)
EC (1) ECSP034437A (en)
ES (1) ES2241849T3 (en)
GT (1) GT200100134A (en)
HK (1) HK1061811A1 (en)
HR (1) HRP20030108B1 (en)
HU (1) HUP0302053A3 (en)
IL (2) IL153873A0 (en)
MX (1) MXPA03000510A (en)
MY (1) MY134521A (en)
NO (1) NO20030222D0 (en)
PE (1) PE20020267A1 (en)
PL (1) PL204593B1 (en)
PT (1) PT1365737E (en)
RS (1) RS50329B (en)
SK (1) SK286162B6 (en)
SV (1) SV2002000557A (en)
TW (1) TWI299729B (en)
UY (1) UY26841A1 (en)
WO (1) WO2002005782A2 (en)
ZA (1) ZA200300469B (en)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6346510B1 (en) 1995-10-23 2002-02-12 The Children's Medical Center Corporation Therapeutic antiangiogenic endostatin compositions
DE10202019A1 (en) * 2002-01-18 2003-07-24 Bayer Ag Pharmaceutical composition, useful in oral formulations for the treatment of e.g. rheumatism, neuralgia, migraine or myocardial infarction, comprises a free-flowing salt of acetylsalicylic acid and a basic amino acid
US8142810B2 (en) 2002-05-30 2012-03-27 The Procter & Gamble Company Dietary method for modulating glucose metabolism and associated conditions and increasing longevity
ES2330321T3 (en) * 2003-05-16 2009-12-09 Cephalon France MODAFINILY SYNTHESIS PROCEDURE.
EP1778652A2 (en) * 2004-08-20 2007-05-02 EntreMed, Inc. Compositions and methods comprising proteinase activated receptor antagonists
US20060166901A1 (en) * 2005-01-03 2006-07-27 Yu Ruey J Compositions comprising O-acetylsalicyl derivatives of aminocarbohydrates and amino acids
DE102005025283A1 (en) * 2005-06-02 2006-12-07 Bayer Healthcare Ag Stable complex of salts of o-acetylsalicylic acid with basic amino acids and glycine
DE102005049293A1 (en) * 2005-10-15 2007-04-26 Bayer Healthcare Ag Combination preparations of salts or o-acetylsalicylic acid
US20090221703A1 (en) 2006-07-09 2009-09-03 Chongxi Yu High penetration composition and uses thereof
AU2006346195B2 (en) 2006-07-09 2013-03-07 Techfields Biochem Co. Ltd Positively charged water-soluble prodrugs of aspirin
US20090238763A1 (en) 2006-07-09 2009-09-24 Chongxi Yu High penetration compositions and uses thereof
JP2010529101A (en) * 2007-06-04 2010-08-26 テックフィールズ インコーポレイテッド NSAIA prodrug with very fast skin and membrane permeation rate and novel pharmaceutical use thereof
DE102008004386A1 (en) * 2008-01-14 2009-07-23 Activaero Gmbh Use of an acetylsalicylic acid salt for the treatment of viral infections
CN101314029B (en) * 2008-06-18 2010-12-08 四川省农业科学院实验场 Acetylsalicylic peptide and preparation method thereof
US20100120727A1 (en) * 2008-11-12 2010-05-13 Kyphia Pharmaceuticals, Inc. Eflornithine Prodrugs, Conjugates and Salts, and Methods of Use Thereof
KR20210123406A (en) 2008-12-04 2021-10-13 충시 위 High Penetration Compositions and Their Applications
EP2445861B1 (en) * 2009-06-25 2014-03-26 Tetra, Sia Novel acetylsalicylic acid salts
CN101633624B (en) * 2009-08-04 2013-05-01 蚌埠丰原医药科技发展有限公司 Preparation method of improved di-lysine-aspirin
FR2950625B1 (en) * 2009-09-30 2016-12-02 Holis Tech PROCESS FOR PREPARING AN O-ACETYLSALICYL ACID SALT OF A BASIC AMINO ACID AND COMPOSITION OBTAINED
FR2965261B1 (en) * 2009-09-30 2012-10-26 Holis Technologies PROCESS FOR THE PREPARATION OF AN O-ACETYLSALICYLIC ACID SALT OF A BASIC AMINO ACID AND COMPOSITION OBTAINED THEREBY
FR2973370B1 (en) * 2011-03-29 2013-05-03 Holis Technologies LOW COST PROCESS FOR THE PREPARATION OF O-ACETYLSALICYCLIC ACID AND BASIC AMINO ACID
CN102503845A (en) * 2011-09-28 2012-06-20 广州普星药业有限公司 Preparation method of DL-lysine aspirin salt and application thereof
EP2849738B1 (en) 2012-05-16 2023-12-06 Techfields Pharma Co., Ltd. High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions
CN102976962B (en) * 2012-11-20 2015-02-04 南京工业大学 L-ornithine-aspirin double salt and its preparation method and use
FR3021654B1 (en) * 2014-05-28 2016-06-24 Unither Pharmaceuticals PROCESS FOR THE PREPARATION OF AN ACETYLSALICYLIC ACID SALT AND A BASIC AMINO ACID
DK3558920T3 (en) * 2016-12-23 2021-07-05 Aspiair Gmbh IMPROVED SYNTHESIS OF LYSINACETYL SALICYLATE-GLYCIN PARTICLES
JP7335232B2 (en) 2017-05-30 2023-08-29 ローシャン ファーマシューティカルズ，インコーポレーテッド Intravial Deposits of Stable, Sterile and Crystalline O-Acetylsalicylic Acid (Aspirin)
KR20200035047A (en) * 2017-08-03 2020-04-01 산텐 세이야꾸 가부시키가이샤 Pharmaceutical composition containing chlorhexidine
CN113105326A (en) * 2021-03-24 2021-07-13 海南卓华制药有限公司 Preparation method and application of aspirin lysine
CN114478287A (en) * 2021-12-31 2022-05-13 蚌埠丰原医药科技发展有限公司 Aspirin-lysine crystal form, preparation method and application
WO2023131645A1 (en) 2022-01-05 2023-07-13 Aspiair Gmbh Improved synthesis of lysine acetylsalicylate · glycine particles

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2115060A1 (en) * 1970-11-26 1972-07-07 Metabio Freeze-dried acetylsalicylates of lysine and arginine - easily prepd derivs of aspirin
ES388158A1 (en) * 1971-02-11 1974-03-16 Liade Sa Lab Procedure for obtaining soluble salts from salicy acetyl acid. (Machine-translation by Google Translate, not legally binding)
JPS4856815A (en) * 1971-11-13 1973-08-09
JPS55127345A (en) * 1979-03-23 1980-10-02 Kyowa Hakko Kogyo Co Ltd Preparation of acetylsalicylic acid salt
JPS5610110A (en) * 1979-07-06 1981-02-02 Green Cross Corp:The Acetyl salicylate salt preparation for injection
JPS56113741A (en) * 1980-02-13 1981-09-07 Mitsui Toatsu Chem Inc Preparation of crystal of acetylsalicylic acid salt
JPS5721345A (en) * 1980-07-15 1982-02-04 Mitsui Toatsu Chem Inc Purification of acetylsalicylate salt
CS247688B1 (en) * 1984-12-22 1987-01-15 Evzen Kasafirek Method of lysine salt with acetylsalicylid acid production
JPS632929A (en) * 1986-06-20 1988-01-07 Kao Corp Acetylsalicylic acid drug preparation
EP0499142A3 (en) * 1991-02-09 1993-05-05 Hoechst Aktiengesellschaft Potentiation of the antireactive-antiasthmatic effect of inhaled loop diuretics by inhaled non steroidal anti-flammatory drugs
DE4332093C2 (en) * 1993-09-22 1995-07-13 Lohmann Therapie Syst Lts Transdermal therapeutic system with the active ingredient acetylsalicylic acid and process for its preparation

Also Published As

Publication number Publication date
TWI299729B (en) 2008-08-11
DE10034802A1 (en) 2002-01-31
US6773724B2 (en) 2004-08-10
DK1365737T3 (en) 2005-07-11
PE20020267A1 (en) 2002-06-08
PL365648A1 (en) 2005-01-10
EP1365737B1 (en) 2005-04-20
CA2416288C (en) 2009-12-22
CN1205176C (en) 2005-06-08
AU2001278471B2 (en) 2004-07-22
HRP20030108A2 (en) 2005-02-28
AU7847101A (en) 2002-01-30
YU2003A (en) 2006-08-17
HUP0302053A3 (en) 2010-03-29
IL153873A (en) 2009-05-04
US20050009791A1 (en) 2005-01-13
AR030305A1 (en) 2003-08-20
JP2012131824A (en) 2012-07-12
NO20030222L (en) 2003-01-16
KR100773658B1 (en) 2007-11-05
JP2004507463A (en) 2004-03-11
ZA200300469B (en) 2004-06-21
CZ2003164A3 (en) 2003-04-16
SK286162B6 (en) 2008-04-07
UY26841A1 (en) 2002-02-28
CA2416288A1 (en) 2003-01-15
GT200100134A (en) 2002-03-22
CZ300337B6 (en) 2009-04-22
WO2002005782A3 (en) 2003-10-02
US20020091108A1 (en) 2002-07-11
EP1365737A2 (en) 2003-12-03
RS50329B (en) 2009-09-08
US7449198B2 (en) 2008-11-11
SK672003A3 (en) 2003-06-03
CN1468209A (en) 2004-01-14
PL204593B1 (en) 2010-01-29
PT1365737E (en) 2005-08-31
BR0112538A (en) 2003-09-09
MY134521A (en) 2007-12-31
NO20030222D0 (en) 2003-01-16
HUP0302053A2 (en) 2003-09-29
IL153873A0 (en) 2003-07-31
ATE293589T1 (en) 2005-05-15
ES2241849T3 (en) 2005-11-01
CR6888A (en) 2004-10-28
HRP20030108B1 (en) 2006-12-31
KR20030019586A (en) 2003-03-06
MXPA03000510A (en) 2004-04-20
DE50105985D1 (en) 2005-05-25
ECSP034437A (en) 2003-03-31
WO2002005782A2 (en) 2002-01-24
SV2002000557A (en) 2002-10-24

Similar Documents

Publication Publication Date Title
HK1061811A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
AU2001278471A1 (en) Stable salts of o-acetylsalicyclic with basic amino acids
HUP0300299A3 (en) Composition comprising free amino acids
GB0018828D0 (en) Alkyl Amino Acid Derivatives useful as pharmaceutical agents
GB9907263D0 (en) Amino acid derivatives
HK1052343A1 (en) Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
IL154031A0 (en) Substituted sulfonylaminomethylbenzoic acid derivatives and preparation
GB0012850D0 (en) Cyclic amino acid derivatives useful as pharmaceutical agents
AU6605601A (en) Beta-amino acid nitrile derivatives
EP1255542A4 (en) Substituted amino acids as neutral sphingomyelinase inhibitors
EP1295865A4 (en) Novel dicarboxylic acid derivatives
SI1337521T1 (en) Salts of an isothiazole-4-carboxamide and their use as anti-hyperproliferation agents
AU6699201A (en) Stable gabapentin having ph within a controlled range
AU1497802A (en) Ss-thio-amino acids
AU3569801A (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors
PL357011A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amide derivatives
AU2001258543A1 (en) Branched amino acids
PL357715A1 (en) Alpha-sulfin- and alpha-sulfonamino acid amide derivatives
GB0025386D0 (en) Branched amino acids
GB0205126D0 (en) Stable storage of proteins
GB0017435D0 (en) 3-arylsulfonyl-2-hydroxy-2-methylpropanoic acid derivatives
SI1317426T1 (en) Beta-thio-amino acids
AUPQ896500A0 (en) Amino acid derivatives
PL357012A1 (en) Novel alpha-sulfin- and alpha-sulfonamino acid amides
SI1255757T1 (en) Amino acid derivatives and use thereof as nep, ace and ece inhibitors

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110705